Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion type Assertion NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_head.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion evidence source_evidence_literature NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion SIO_000772 9259972 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion wasDerivedFrom befree-20150227 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion wasGeneratedBy ECO_0000203 NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.